Assessing physicians' preferences on skin cancer treatment in Europe

British Journal of Dermatology

Volumn 167, Issue SUPPL. 2, 2012, Pages 29-35

  Ferrandiz, L ^a   Ruiz De Casas, A ^a   Trakatelli, M ^b   De Vries, E ^c   Ulrich, M ^d   Aquilina, S ^e   Saksela, O ^f   Majewski, S ^g   Ranki, A ^f   Proby, C ^h   Magnoni, C ⁱ   Pitkanen S ^f   Kalokasidis, K ^b   Siskou, S ^b   Hinrichs, B ^d   Altsitsiadis, E ^d,j   Stockfleth, E ^d   Moreno Ramirez, D ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^b PAPAGEORGIOU GENERAL HOSPITAL   (Greece)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e Sir Paul Boffa Hospital   (Malta)

^f HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^g MEDICAL UNIVERSITY OF WARSAW   (Poland)

^h UNIVERSITY OF DUNDEE   (United Kingdom)

ⁱ UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^j UNIVERSITY OF LEUVEN   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; FLUOROURACIL; HYALURONIC ACID; IMIQUIMOD;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; BOWEN DISEASE; CANCER CHEMOTHERAPY; CANCER SURGERY; CASE CONTROL STUDY; CRYOTHERAPY; CURETTAGE; EXCISION; FEMALE; FINLAND; GERMANY; GREECE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MALTA; MELANOMA; MULTICENTER STUDY; PHOTODYNAMIC THERAPY; PHYSICIAN ATTITUDE; POLAND; PRIORITY JOURNAL; QUESTIONNAIRE; SKIN CANCER; SKIN FLAP; SKIN GRAFT; SPAIN; SQUAMOUS CELL CARCINOMA; TREATMENT PLANNING; UNITED KINGDOM;

AGED; AGED, 80 AND OVER; ATTITUDE OF HEALTH PERSONNEL; CASE-CONTROL STUDIES; DERMATOLOGY; EUROPE; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; SKIN NEOPLASMS;

EID: 84865020450     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.11084.x     Document Type: Article

References (17)

1. Stockfleth E, Terhorst D, Braathen L, et al. Guideline on Actinic Keratoses. 2011. Available at: http://www.euroderm.org/images/stories/ guidelines/guideline-Management-Actinic-Keratoses-update2011.pdf (last accessed 11 April 2012).
2. De Berker D, McGregor JM, Hughets BR, et al. Guidelines for the management of actinic keratoses. Br J Dermatol 2007; 156: 222-30.
3. Telfer NR, Colver GB, Morton CA,. Guidelines for the management of basal cell carcinoma. Br J Dermatol 2008; 159: 35-48.
4. Cox NH, Eedy DJ, Morton CA, et al. Guidelines for the management of Bowen's disease: 2006 update. Br J Dermatol 2007; 156: 11-21.
5. Seretis K, Thomaidis V, Karpouzis A, et al. Epidemiology of surgical treatment of nonmelanoma skin cancer in the head and neck in Greece. Dermatol Surg 2010; 36: 15-22.
6. Essers BA, Dirksen CD, Prins MH, Neumann HA,. Assessing the public's preference for surgical treatment of primary basal cell carcinoma: a discrete-choice experiment in the south of the Netherlands. Dermatol Surg 2010; 36: 1950-5.
7. Bath-Hextall F, Bong J, Perkins W, Williams H,. Interventions for basal cell carcinoma of the skin: systematic review. BMJ 2004; 329: 705.
8. Schmook T, Stockfleth E,. Current treatment patterns in non-melanoma skin cancer across Europe. J Dermatolog Treat 2003; 14 (Suppl. 3): 3-10.
9. De Vries E, Trakatelli M, Kalabalikis D, et al. Known and potential new risk factors for skin cancer in European populations: a multicentre case-control study. Br J Dermatol 2012; 167 (Suppl. 2): 1-13.
10. Mosterd K, Krekels GA, Nieman FH, et al. Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up. Lancet Oncol 2008; 9: 1149-56.
11. Blazquez-Sanchez N, de Troya-Martin M, Frieyro-Elicegui M, et al. Cost analysis of Mohs micrographic surgery in high-risk facial basal cell carcinoma. Actas Dermosifiliogr 2010; 101: 622-8.
12. Essers BA, Dirksen CD, Nieman FH, et al. Cost-effectiveness of Mohs micrographic surgery vs surgical excision of basal cell carcinoma of the face. Arch Dermatol 2006; 142: 187-94.
13. Schulze HJ, Cribier B, Requena L, et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe. Br J Dermatol 2005; 152: 939-47.
14. Warino L, Tusa M, Camacho F, et al. Frequency and cost of actinic keratosis treatment. Dermatol Surg 2006; 32: 1045-9.
15. Ulrich C,. Topical treatment of field cancerization. Cancer Treat Res 2009; 146: 439-46.
16. Ulrich M, Stockfleth E,. Field treatment of actinic keratoses-focus on COX-2-inhibitors. Actas Dermosifiliogr 2009; 100 (Suppl. 2): 55-8.
17. Stockfleth E, Sterry W,. New treatment modalities for basal cell carcinoma. Recent Results Cancer Res 2002; 160: 259-68.